Archive:Aducanumab
-
Alzheimer’s Association On Demand Webinars
View some free, on demand webinars regarding a variety of Alzheimer's topics including Aducanmunab on the Alzheimer's Association website. View Here https://www.alz.org/research/for_researcher
Categories: Aducanumab, Events, News
-
Aducanumab (AduhelmTM) – the first disease-modifying treatment for Alzheimer’s disease approved by the US Food and Drug Administration, 7 June 2021
Availability of Aduhelm remains unclear Coverage by Medicare and other third-party payers unknown More information to follow R. Scott Turner, PhD, MD, and the Memory Disorders Program On
Category: News